Trial Profile
A Randomized, Masked, Vehicle-controlled Clinical Trial to Assess the Safety and Efficacy of PVP-I (0.4%)/Dexamethasone (0.1%) Ophthalmic Suspension (Foresight Biotherapeutics, Inc) in the Treatment of Acute Adenoviral Conjunctivitis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2021
Price :
$35
*
At a glance
- Drugs Povidone iodine/dexamethasone (Primary)
- Indications Conjunctivitis
- Focus Therapeutic Use
- Sponsors Foresight Biotherapeutics
- 22 Oct 2014 New trial record